Galectin Therapeutics (GALT) Interest Coverage Ratio (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.17% |
| Dec 31, 2025 | 24.76% |
| Sep 30, 2025 | 8.93% |
| Jun 30, 2025 | 44.06% |
| Mar 31, 2025 | 37.15% |
| Dec 31, 2024 | -18.73% |
| Sep 30, 2024 | 31.80% |
| Jun 30, 2024 | 2.98% |
| Mar 31, 2024 | 18.75% |
| Dec 31, 2023 | -2.83% |
| Sep 30, 2023 | 20.75% |
| Jun 30, 2023 | 38.39% |
| Mar 31, 2023 | 34.88% |
| Dec 31, 2022 | -14.34% |
| Sep 30, 2022 | 28.44% |
| Jun 30, 2022 | 3.60% |
| Mar 31, 2022 | -60.33% |
| Dec 31, 2021 | 97.68% |
| Sep 30, 2021 | -1,121.84% |
| Jun 30, 2021 | 66.43% |
| Mar 31, 2021 | 19.34% |
| Dec 31, 2020 | -32.16% |
| Sep 30, 2020 | 7.30% |
| Jun 30, 2020 | -78.36% |
| Mar 31, 2020 | 30.92% |
| Dec 31, 2019 | -81.21% |
| Sep 30, 2019 | 9.51% |
| Jun 30, 2019 | -33.66% |
| Mar 31, 2019 | -188.35% |
| Dec 31, 2018 | -21.13% |
| Sep 30, 2018 | 30.34% |
| Jun 30, 2018 | 11.09% |